These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 22983586

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.
    Dika E, Barisani A, Vaccari S, Fanti PA, Ismaili A, Patrizi A.
    J Drugs Dermatol; 2013 May; 12(5):512-3. PubMed ID: 23652942
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
    Lau YM, Lam YK, Leung KH, Lin SY.
    Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months.
    Suemori K, Fujiwara H, Watanabe S, Azuma T, Yasukawa M.
    Int J Hematol; 2010 Dec; 92(5):777-8. PubMed ID: 21110146
    [No Abstract] [Full Text] [Related]

  • 31. Imatinib-induced Stevens-Johnsons syndrome.
    Jha P, Himanshu D, Jain N, Singh AK.
    BMJ Case Rep; 2013 Jan 23; 2013():. PubMed ID: 23349042
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia].
    Martínez Pascual C, Valdés Mas M, de la Peña Moral JM, Miras López M.
    Med Clin (Barc); 2011 Sep 17; 137(7):329-30. PubMed ID: 21074222
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.
    Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Verstovsek S, Giles F, Rios MB, Shan J, Letvak L, Thomas D, Faderl S, Ferrajoli A, Cortes J.
    Blood; 2004 Apr 15; 103(8):2873-8. PubMed ID: 15070658
    [Abstract] [Full Text] [Related]

  • 36. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
    Druker BJ.
    Expert Opin Pharmacother; 2003 Jun 15; 4(6):963-71. PubMed ID: 12783592
    [Abstract] [Full Text] [Related]

  • 37. Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect.
    Georgalas I, Pavesio C, Ezra E.
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct 15; 245(10):1585-6. PubMed ID: 17562067
    [No Abstract] [Full Text] [Related]

  • 38. Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients.
    Dora JM, Leie MA, Netto B, Fogliatto LM, Silla L, Torres F, Maia AL.
    Eur J Endocrinol; 2008 May 15; 158(5):771-2. PubMed ID: 18426838
    [No Abstract] [Full Text] [Related]

  • 39. Multiple eruptive dermatofibromas related to imatinib treatment.
    Llamas-Velasco M, Fraga J, Solano-López GE, Steegmann JL, García Diez A, Requena L.
    J Eur Acad Dermatol Venereol; 2014 Jul 15; 28(7):979-81. PubMed ID: 24321053
    [No Abstract] [Full Text] [Related]

  • 40. Acute renal failure secondary to imatinib mesylate treatment in chronic myeloid leukemia.
    Pou M, Saval N, Vera M, Saurina A, Solé M, Cervantes F, Botey A.
    Leuk Lymphoma; 2003 Jul 15; 44(7):1239-41. PubMed ID: 12916879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.